Innodata Isogen Inc. : Innodata Announces First Major Synodex Contract

    Innodata Isogen Inc. : Innodata Announces First Major Synodex Contract



               Innodata Announces First Major Synodex Contract

NEW YORK - April 8, 2013 -  INNODATA INC. (NASDAQ: INOD) announced today  that 
its Synodex subsidiary has signed a two-year services contract with a  Fortune 
1000 life insurance company. Based on initially expected volumes, the  Company 
anticipates that the contract's revenue value will approximate $1,400,000 over
the two years of the contract.

Synodex utilizes a proprietary platform to transform medical data from  health 
records into  concise, highly-structured  human-readable  reports as  well  as 
computer-readable XML data. Life insurance  companies can use Synodex  reports 
to support underwriter decision-making and can  use Synodex XML data to  power 
automated systems.

Jack Abuhoff, Innodata's Chairman and CEO, said, "Synodex began marketing  its 
products in October 2012 and has since completed 12 pilot programs with  large 
insurance companies and brokers.  Our pilot programs  are being received  with 
interest and our roster of prospects continues to grow.

"We are pleased  that our marketing  program has now  yielded its first  major 
contract. We believe that the contract provides significant validation of  our 
innovation and platform."

    About Innodata and Synodex

Innodata (NASDAQ: INOD)  operates through  its Content  and Innodata  Advanced 
Data Solutions (IADS) segments. The Content  segment is a leading provider  of 
business  process,  information  technology   and  professional  services   to 
publishers, information providers, and other  enterprises that are focused  on 
digital enablement. Clients of this segment include leading media,  publishing 
and information services companies, as well as enterprises that are  prominent 
in  information  technology,  manufacturing,  aerospace,  defense,   financial 
services, government, healthcare,  insurance, intelligence, manufacturing  and 

Synodex is an IADS  subsidiary that designs and  develops new capabilities  to 
enable clients in  the insurance,  medical and healthcare  sectors to  improve 
decision-support through digital technologies.  Synodex offers the ability  to 
unlock the contents of paper and  imaged medical documents and turn them  into 
usable information. Synodex operations are  HIPAA, DPA and SSAE 16SOC  1Type 
II compliant, and are  also ISO 27001 certified.  Synodex and Innodata are  on 
the US Safe Harbor registry.

Recent Innodata  honors  include  EContent Magazine's  EContent  100,  KMWorld 
Magazine's  100   Companies  That   Matter   in  Knowledge   Management,   the 
International  Association   of  Outsourcing   Professionals'  (IAOP)   Global 
Outsourcing Top 100, D&B India's Leading ITeS and BPO Companies and the  Black 
Book of Outsourcing's Top List ofLeading Outsourcing Providers to the Printing
and Publishing Business.

Headquartered in the New York metro area, Innodata has offices and  operations 
in the United States,  the United Kingdom, Israel,  India, Sri Lanka, and  the 

This release contains forward-looking statements that are made pursuant to the
safe harbor  provisions of  the Private  Securities Litigation  Reform Act  of 
1995. The  words  "project,"  "head  start,"  "believe,"  "expect,"  "should," 
"anticipate," "indicate," "point  to," "forecast,"  "likely"and other  similar 
expressions generally identify forward-looking statements, which speak only as
of their dates.

These  forward-looking   statements  are   based   largely  on   our   current 
expectations, and  are  subject  to  a  number  of  risks  and  uncertainties, 
including without limitation, that contracts  could be terminated by  clients, 
projected or committed volumes of work may not materialize; that our  Innodata 
Advanced Data Solutions segment has  not reported any substantial revenues  to 
date and is subject to the  risks and uncertainties of early-stage  companies; 
the primarily  at-will nature  of the  contracts with  our customers  and  the 
ability of customers to reduce,  delay or cancel projects; continuing  Content 
Services revenue concentration  in a limited  number of customers;  continuing 
Content Services reliance on project-based work; inability to replace projects
that are completed, cancelled or reduced; depressed market conditions; changes
in external market factors; the ability  and willingness of our customers  and 
prospective  customers  to   execute  business  plans   which  give  rise   to 
requirements for  digital  content  and  professional  services  in  knowledge 
processing;  difficulty   in   integrating   and   deriving   synergies   from 
acquisitions, joint venture and strategic investments; potential  undiscovered 
liabilities of companies that  we acquire; changes in  our business or  growth 
strategy;  the  emergence  of  new  or  growing  competitors;  various   other 
competitive and  technological  factors;  and other  risks  and  uncertainties 
indicated from time to  time in our filings  with the Securities and  Exchange 

We undertake no  obligation to  update or review  any guidance  or changes  in 
status of customer contracts,  client relationships, or other  forward-looking 
information, whether as a  result of new  information, future developments  or 
otherwise. Actual results could differ materially from the results referred to
in the forward-looking statements. In light of these risks and  uncertainties, 
there can be no assurance that the results referred to in the  forward-looking 
statements contained in this release will occur.

Company Contact

Raj Jain
Vice President
Innodata Isogen, Inc.
(201) 371-8024


Media Contact
Stanley or Andrew Berger
SM Berger & Company
(216) 464-6400


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Innodata Isogen Inc. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.